News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
634,470 Results
Type
Article (60761)
Company Profile (82)
Press Release (573627)
Section
Business (173374)
Career Advice (2718)
Deals (32372)
Drug Delivery (91)
Drug Development (76735)
Employer Resources (148)
FDA (14852)
Job Trends (13834)
News (304341)
Policy (28872)
Tag
Academia (2869)
Alliances (42877)
Alzheimer's disease (1200)
Approvals (14821)
Artificial intelligence (149)
Bankruptcy (280)
Best Places to Work (10804)
Breast cancer (183)
Cancer (1327)
Cardiovascular disease (102)
Career advice (2298)
CAR-T (95)
Cell therapy (285)
Clinical research (61286)
Collaboration (460)
Compensation (160)
COVID-19 (2523)
C-suite (121)
Data (1361)
Diabetes (159)
Diagnostics (5958)
Earnings (58586)
Employer resources (131)
Events (92317)
Executive appointments (410)
FDA (15531)
Funding (420)
Gene therapy (189)
GLP-1 (562)
Government (4391)
Healthcare (18105)
Infectious disease (2607)
Inflammatory bowel disease (111)
Interviews (523)
IPO (14637)
Job creations (3407)
Job search strategy (1937)
Layoffs (445)
Legal (6387)
Lung cancer (187)
Manufacturing (187)
Medical device (12502)
Medtech (12507)
Mergers & acquisitions (17945)
Metabolic disorders (418)
Neuroscience (1503)
NextGen Class of 2024 (6357)
Non-profit (4305)
Northern California (1530)
Obesity (228)
Opinion (209)
Parkinson's disease (93)
Patents (118)
People (58665)
Phase I (19266)
Phase II (27056)
Phase III (19736)
Pipeline (482)
Postmarket research (2470)
Preclinical (8206)
Radiopharmaceuticals (239)
Rare diseases (250)
Real estate (5968)
Regulatory (19500)
Research institute (2384)
Resumes & cover letters (406)
Southern California (1346)
Startups (3328)
United States (13831)
Vaccines (546)
Weight loss (157)
Date
Today (118)
Last 7 days (566)
Last 30 days (2306)
Last 365 days (32305)
2024 (32169)
2023 (36337)
2022 (46627)
2021 (51580)
2020 (50735)
2019 (44778)
2018 (34058)
2017 (30712)
2016 (30063)
2015 (35455)
2014 (28393)
2013 (24957)
2012 (26216)
2011 (26460)
2010 (24934)
Location
Africa (865)
Arizona (139)
Asia (37501)
Australia (6746)
California (3426)
Canada (1330)
China (282)
Colorado (163)
Connecticut (169)
Europe (87095)
Florida (499)
Georgia (132)
Illinois (398)
Indiana (201)
Maryland (589)
Massachusetts (2534)
Michigan (176)
Minnesota (244)
New Jersey (1043)
New York (990)
North Carolina (746)
Northern California (1530)
Ohio (135)
Pennsylvania (826)
South America (1172)
Southern California (1346)
Texas (517)
Utah (105)
Washington State (363)
634,470 Results for "university of calgary".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)
Arch Biopartners Inc. announced today that the University of Calgary’s Conjoint Health Research Ethics Board (CHREB) has approved the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
June 18, 2024
·
5 min read
Business
University of Calgary Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that a research team from the University of Calgary’s Cumming School of Medicine has joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).
March 15, 2024
·
5 min read
The Alberta Cancer Foundation, Alberta Health Services and the University of Calgary announce largest donation in Alberta Health Service’s history to the new Calgary Cancer Centre
The Alberta Cancer Foundation, Alberta Health Services and the University of Calgary are thrilled to announce a historic and transformational $50 million donation to the Calgary Cancer Centre from the Arthur J.E. Child Foundation.
June 28, 2023
·
7 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Business
Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers
Provectus Biopharmaceuticals, Inc. today announced that data from preclinical research by the University of Calgary on oral administration of Provectus’s pharmaceutical-grade rose bengal for the treatments of solid tumor cancers were published in the open access journal of oncology Cancers.
April 18, 2024
·
4 min read
Bio NC
Pfizer invests $4.9M in McMaster University study to help improve care for multiple myeloma patients in Canada
Pfizer is proud to announce that it is supporting a McMaster University-led study, through the Ontario Clinical Oncology Group, that aims to improve care for Canadians living with multiple myeloma.
June 3, 2024
·
5 min read
BioMidwest
University of Cincinnati Cancer Center Launches Nation’s Most Comprehensive Blood Cancer Healing Center
The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.
June 24, 2024
·
4 min read
Business
Enveric Biosciences and University of Calgary Collaborate on a Groundbreaking Clinical Trial for EVM-101 in Cancer Related Distress
Enveric Biosciences is working with the University of Calgary’s Hotchkiss Brain Institute (“HBI”) to establish a groundbreaking clinical trial of EVM-101 for the treatment of Cancer Related Distress (“CRD”).
February 17, 2022
·
7 min read
Press Releases
Naropa University Announces Separation of Center For Psychedelic Studies
December 16, 2024
·
4 min read
1 of 63,447
Next